Elena Elimova

Medical Oncology Physician in Houston, TX

NPI: 1649679929

Get Contact Info for Free

email

Get Dr. Elena's Emailcall

HQ Phone

Get Dr. Elena's Phone Numberphone_android

Mobile

Get Dr. Elena's Mobile

Overview

EHR

Specialty

Procedures

Certifications

Education

Publications

Clinical Trials

Insurance Plans

About Elena Elimova

Dr. Elena Elimova is an oncologist in Houston, Texas. She received her medical degree from Memorial University of Newfoundland FOM and has been in practice between 11-20 years.

NPI

1649679929

Get Email for Free

Mobile

Get Mobile for Free

Corporate Phone

Get Phone for Free

Technology Used by Elena Elimova

Which EHR is used by Elena Elimova?

Elena Elimova uses *** EHR.

Unlock Technology Stack

Looking to connect with more Physicians?

Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.

Get Started for Free

Dr. April Adams Szafran, MD, PhD Specialties

PRIMARY SPECIALTY

UrologyTaxonomy: 208800000XState: ILLicense Number: 036147430

SUBSPECIALTIES

Male Sexual Dysfunction, Male Sexual Dysfunction, Male Sexual Dysfunction

PRIMARY SPECIALTY

UrologyTaxonomy: 208800000XState: ILLicense Number: 036147430

SUBSPECIALTIES

Male Sexual Dysfunction, Male Sexual Dysfunction, Male Sexual Dysfunction

Elena Elimova Certifications & Licensure

STATE LICENSES

TX State Medical License

2014 - 2024

BOARD CERTIFICATIONS

American Board of Internal Medicine

Internal Medicine

American Board of Internal Medicine

Medical Oncology

Elena Elimova Education & Training

Memorial University of Newfoundland FOM

Medical School

Until 2008

Elena Elimova Publications

Leptomeningeal carcinomatosis and brain metastases in gastroesophageal carcinoma: a real-world analysis of clinical and pathologic characteristics and outcomes.

Authors: Lucy Ma

Journal: J Neurooncol

Publication Date: 2024-02-19

Brain NeoplasmsCarcinomaHumansRetrospective StudiesProportional Hazards ModelsMeningeal Carcinomatosis

Impact of adjuvant therapy in patients with a microscopically positive margin after resection for gastric and esophageal cancers.

Authors: Lucy Ma

Elena Elimova Clinical Trials5 Clinical Trials

Phase 2 Study of ZW25 Plus First-line Combination Chemotherapy in HER2-Expressing Gastrointestinal (GI) Cancers, Including Gastroesophageal Adenocarcinoma (GEA), Biliary Tract Cancer (BTC), and Colorectal Cancer (CRC)

COMPLETED

Lead Sponsor: Jazz Pharmaceuticals

Intervention / Treatment: DRUG: Cisplatin, DRUG: Capecitabine, DRUG: Gemcitabine, DRUG: Fluorouracil, DRUG: Bevacizumab, DRUG: Oxaliplatin, DRUG: Leucovorin, DRUG: ZW25 (Zanidatamab)

Conditions:HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer

Multi-Omic Assessment of Squamous Cell Cancers Receiving Systemic Therapy

ACTIVE_NOT_RECRUITING

Lead Sponsor: University Health Network, Toronto

Frequently asked questions regarding Elena Elimova

Elena Elimova's email address is available to verified Dmand AI users. Their primary practice is located at in Houston, Texas. Sign up for a free trial to reveal their direct contact information.

Elena Elimova's direct phone number is available to Dmand AI subscribers. To access their direct number, start a free trial.

Elena Elimova is a Medical Oncology Physician physician currently practicing at in Houston, Texas. They hold admitting privileges at 0 hospital(s), including . To see all the affiliations of Elena Elimova, start a free trial.

Elena Elimova is a board-certified Medical Oncology Physician physician with a subspecialty in Medical Oncology. They practice at in Houston, Texas.

Elena Elimova performs procedures across 0 clinical categories. Their most commonly billed procedures based on Medicare claims data include , , and . Full procedure and CPT code data is available to Dmand AI subscribers, start a free trial.

Elena Elimova's National Provider Identifier (NPI) is 1649679929. This is a public identifier issued by CMS and can be verified at the NPPES NPI Registry. Their primary taxonomy code is 207RX0202X, corresponding to Medical Oncology Physician.

The EHR and practice technology used by Elena Elimova at is available to Dmand AI subscribers. Sign up for a free trial to unlock the full technology stack.

Elena Elimova accepts 0 insurance plans. A full list of accepted payers is available in the profile above.

Elena Elimova holds hospital privileges at 0 institution(s). Their primary affiliation is in , .

Elena Elimova is board certified by American Board of Internal Medicine in Internal Medicine with subspecialty certification in Medical Oncology. They have maintained this certification since .

Elena Elimova received their medical degree from Memorial University of Newfoundland FOM in 2008. They completed their residency at .

Based on CMS Medicare Part B claims data, Elena Elimova served approximately 0 Medicare beneficiaries in 2023. Total patient volume including non-Medicare patients is available to Dmand AI subscribers.

Elena Elimova's group practice affiliation details are available to Dmand AI subscribers.

Elena Elimova has 119 indexed publications on record and has been listed as a principal investigator on 5 clinical trial(s). Their research activity is available to Dmand AI subscribers. Sign up for a free trial to unlock their full research activity.

The Dmand Booster 🚀

Elena Elimova

Frequently asked questions regarding Elena Elimova

Identify. Engage. Convert.